Skip to main content
Livermore
Livermore
ZHEN

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−1,689,629−100.0%Sold outHolders
Q3 20251,689,629$80.2M<0.1%+153,429+10.0%AddedHolders
Q2 20251,536,200$82.0M<0.1%+284,831+22.8%AddedHolders
Q1 20251,251,369$50.7M<0.1%−587,912−32.0%ReducedHolders
Q4 20241,839,281$51.2M<0.1%−177,807−8.8%ReducedHolders
Q3 20242,017,088$57.9M<0.1%+109,231+5.7%AddedHolders
Q2 20241,907,857$44.8M<0.1%+286,595+17.7%AddedHolders
Q1 20241,621,262$41.0M<0.1%+13,571+0.8%AddedHolders
Q4 20231,607,691$37.5M<0.1%+325,981+25.4%AddedHolders
Q3 20231,281,710$64.8M<0.1%+1,161,305+964.5%AddedHolders
Q2 2023120,405$5.62M<0.1%+46,515+63.0%AddedHolders
Q1 202373,890$2.83M<0.1%+39,310+113.7%AddedHolders
Q4 202234,580$1.89M<0.1%+10,052+41.0%AddedHolders
Q3 202224,528$835.0K<0.1%+3,128+14.6%AddedHolders
Q2 202221,400$202.0K<0.1%+5,400+33.8%AddedHolders
Q1 202216,000$227.0K<0.1%00.0%UnchangedHolders
Q4 202116,000$338.0K<0.1%00.0%UnchangedHolders
Q3 202116,000$358.0K<0.1%−2,900−15.3%ReducedHolders
Q2 202118,900$469.0K<0.1%+4,200+28.6%AddedHolders
Q1 202114,700$426.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.